224 related articles for article (PubMed ID: 19187269)
21. Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.
Wonodi I; Schwarcz R
Schizophr Bull; 2010 Mar; 36(2):211-8. PubMed ID: 20147364
[TBL] [Abstract][Full Text] [Related]
22. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
[TBL] [Abstract][Full Text] [Related]
23. Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2002 Mar; 109(3):239-49. PubMed ID: 11956948
[TBL] [Abstract][Full Text] [Related]
24. Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges.
Albuquerque EX; Schwarcz R
Biochem Pharmacol; 2013 Apr; 85(8):1027-32. PubMed ID: 23270993
[TBL] [Abstract][Full Text] [Related]
25. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II.
Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM
Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557
[TBL] [Abstract][Full Text] [Related]
26. Glutamate-dopamine crosstalk in the rat prefrontal cortex is modulated by Alpha7 nicotinic receptors and potentiated by PNU-120596.
Livingstone PD; Dickinson JA; Srinivasan J; Kew JN; Wonnacott S
J Mol Neurosci; 2010 Jan; 40(1-2):172-6. PubMed ID: 19688191
[TBL] [Abstract][Full Text] [Related]
27. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling.
Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240
[TBL] [Abstract][Full Text] [Related]
28. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats.
Luchowski P; Luchowska E; Turski WA; Urbanska EM
Neurosci Lett; 2002 Sep; 330(1):49-52. PubMed ID: 12213632
[TBL] [Abstract][Full Text] [Related]
29. Presynaptic kynurenate-sensitive receptors inhibit glutamate release.
Carpenedo R; Pittaluga A; Cozzi A; Attucci S; Galli A; Raiteri M; Moroni F
Eur J Neurosci; 2001 Jun; 13(11):2141-7. PubMed ID: 11422455
[TBL] [Abstract][Full Text] [Related]
30. Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.
Sathyasaikumar KV; Stachowski EK; Wonodi I; Roberts RC; Rassoulpour A; McMahon RP; Schwarcz R
Schizophr Bull; 2011 Nov; 37(6):1147-56. PubMed ID: 21036897
[TBL] [Abstract][Full Text] [Related]
31. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons.
Rzeski W; Kocki T; Dybel A; Wejksza K; Zdzisińska B; Kandefer-Szerszeń M; Turski WA; Okuno E; Albrecht J
J Neurosci Res; 2005 Jun; 80(5):677-82. PubMed ID: 15880762
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.
Pershing ML; Bortz DM; Pocivavsek A; Fredericks PJ; Jørgensen CV; Vunck SA; Leuner B; Schwarcz R; Bruno JP
Neuropharmacology; 2015 Mar; 90():33-41. PubMed ID: 25446576
[TBL] [Abstract][Full Text] [Related]
33. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
34. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats.
Kozak R; Martinez V; Young D; Brown H; Bruno JP; Sarter M
Neuropsychopharmacology; 2007 Oct; 32(10):2074-86. PubMed ID: 17299502
[TBL] [Abstract][Full Text] [Related]
35. Formation of endogenous glutamatergic receptors antagonist kynurenic acid--differences between cortical and spinal cord slices.
Urbańska EM; Chmielewski M; Kocki T; Turski WA
Brain Res; 2000 Sep; 878(1-2):210-2. PubMed ID: 10996154
[TBL] [Abstract][Full Text] [Related]
36. Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro.
Chmiel-Perzyńska I; Kloc R; Perzyński A; Rudzki S; Urbańska EM
Neurotox Res; 2011 Jul; 20(1):40-50. PubMed ID: 20838951
[TBL] [Abstract][Full Text] [Related]
37. Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus.
Liu Y; Ford B; Mann MA; Fischbach GD
J Neurosci; 2001 Aug; 21(15):5660-9. PubMed ID: 11466437
[TBL] [Abstract][Full Text] [Related]
38. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy.
Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J
J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457
[TBL] [Abstract][Full Text] [Related]
39. Involvement of nicotinic and muscarinic receptors in the endogenous cholinergic modulation of the balance between excitation and inhibition in the young rat visual cortex.
Lucas-Meunier E; Monier C; Amar M; Baux G; Frégnac Y; Fossier P
Cereb Cortex; 2009 Oct; 19(10):2411-27. PubMed ID: 19176636
[TBL] [Abstract][Full Text] [Related]
40. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
